Sana Biotechnology, Inc.
SANA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $651 | $399 | $385 |
| - Cash | $103 | $71 | $96 | $128 |
| + Debt | $75 | $85 | $91 | $94 |
| Enterprise Value | – | $665 | $394 | $352 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$39 | -$48 | -$47 | -$45 |
| % Margin | – | – | – | – |
| Net Income | -$42 | -$94 | -$49 | -$49 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.16 | -0.39 | -0.21 | -0.21 |
| % Growth | 59% | -85.7% | 0% | – |
| Operating Cash Flow | -$29 | -$33 | -$49 | -$47 |
| Capital Expenditures | -$0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$29 | -$33 | -$49 | -$48 |